Wuhan General Group (China), Inc. (OTC:WUHN)
Industry: Drug Manufacturers - Specialty & Generic

OFF LIST - 787 consecutive market days: OFF LIST as of 04/19/2013 Through 11/14/2016

Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.

Current Quote*
Last: $0.000
Change: 0.000
Book: $0.019
Volume: 59,588

As Of: 07/01 16:07 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol WUHN

  • No BuyIns.Net Alerts Available for WUHN

Graphs for WUHN


3 Month Graph


6 Month Graph


1 Year Graph